October 22, 2016 9:45 PM ET


Company Overview of Twinstrand Therapeutics, Inc.

Company Overview

As of July 7, 2009, Twinstrand Therapeutics, Inc. was acquired by Cangene Corp. Twinstrand Therapeutics, Inc. operates as a biopharmaceutical company which engages in the discovery, development, and commercialization of biological drugs for the treatment of life-threatening diseases. Its products include TST10088, a recombinant protein-based prodrug for activation by matrix metalloproteinases associated with solid tumor forms of cancer. The company was formerly known as De Novo Enzyme Corporation and changed its name to Twinstrand Therapeutics, Inc. in January 2000. The company was founded in 1995 and is based in North Vancouver, Canada.

267 West Esplanade

Suite 309

North Vancouver, BC V7M 1A5


Founded in 1995





Key Executives for Twinstrand Therapeutics, Inc.

Twinstrand Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
2007262 Ontario, Inc. Americas
2056273 Ontario, Inc. Americas
AB BioPharma Inc. Americas
AbCelex Technologies Inc. Americas
AbCellera Biologics Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Twinstrand Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.